ODRE 2005 SLU 13D and 13G filings for Theravance Biopharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-06-11 4:17 pm Sale |
2024-05-10 | 13G | Theravance Biopharma, Inc. TBPH |
ODRE 2005 SLU | 0 0.000% |
-4,108,318 (Position Closed) |
Filing |
| 2022-04-21 11:08 am Purchase |
2022-03-18 | 13G | Theravance Biopharma, Inc. TBPH |
ODRE 2005 SLU | 4,108,318 5.500% |
4,108,318 (New Position) |
Filing |